Member Article

Concept Life Sciences appoints Matthew S Jones, life sciences industry leader, as Chief Commercial Officer

14 July 2014

Concept Life Sciences, an international scientific laboratory and consultancy business, with a combined enterprise value approaching $100 million, has today announced the appointment of Matthew S. Jones as Chief Commercial Officer. In this role, Mr Jones will be responsible for leading Concepts’ global commercial organisation, which encompasses all sales, business development, marketing activities, and strategic partnering efforts.

A veteran of the life sciences industry with almost two decades of experience, Jones joins Concept Life Sciences having transformed, led and driven commercial growth strategies for a diverse range of life science businesses both in Europe and the US. Prior to joining Concept Life Sciences he served as Executive Vice President at Human Care Systems Inc, Vice President Global Head Sales & Business Development at Lonza Biologics, Vice President of Business Development & Marketing at Ricerca BioSciences LLC , and Vice President of Business Development at MDS Pharma Services Inc. He has also held senior level clinical leadership roles within the biopharmaceutical industry with Alkemes Inc and GlaxoSmithKline.

Commenting on the appointment Concept Chief Executive Officer Alan Morgan said: “Matthew’s experience working on, and developing, innovative commercial solutions for the biopharmaceutical industry is a tremendous addition to our world-class team. His expertise will assist our growth across our expanding service portfolio of analytical testing, complex chemistry synthesis, biological sciences, cell based ADME, environmental & food consulting, biostorage and stability testing services.”

Jones said: “I am extremely excited to be joining Concept Life Sciences and leading a true, world-class science led organisation. The commercial landscape continues to evolve at an incredible pace that requires innovative thinking, diverse expertise and flawless execution. Concept Life Sciences is well positioned to succeed in this environment, and I look forward to ensuring our team continues to lead and deliver for our biopharma, food and environmental science customers around the world.

Concept Life Sciences is currently focused on laboratory based analytical testing and complex chemistry synthesis and will be accelerating its investment in biological sciences, cell based ADME services, biostorage and stability testing. The group currently has over 500 staff in ten core locations, with advanced plans to expand into continental Europe and the USA.

This was posted in Bdaily's Members' News section by VPR .